Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2014, Article ID 260549, 8 pages
http://dx.doi.org/10.1155/2014/260549
Review Article

p16INK4A and p14ARF Gene Promoter Hypermethylation as Prognostic Biomarker in Oral and Oropharyngeal Squamous Cell Carcinoma: A Review

1Department of Pathology, University Medical Centre Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands
2Department of Radiation Oncology, University Medical Centre Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands
3Department of Otorhinolaryngology, University Medical Centre Utrecht, P.O. Box 85500, 3508 GA Utrecht, The Netherlands

Received 26 November 2013; Accepted 17 March 2014; Published 7 April 2014

Academic Editor: Silvia Persichilli

Copyright © 2014 A. Al-Kaabi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Ferlay, H. Shin, F. Bray, D. Forman, C. Mathers, and D. M. Parkin, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008,” International Journal of Cancer, vol. 127, no. 12, pp. 2893–2917, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. E. E. Vokes, R. R. Weichselbaum, S. M. Lippman, and W. K. H. Waun Ki Hong, “Medical progress: head and neck cancer,” New England Journal of Medicine, vol. 328, no. 3, pp. 184–194, 1993. View at Publisher · View at Google Scholar · View at Scopus
  3. C. R. Leemans, B. J. M. Braakhuis, and R. H. Brakenhoff, “The molecular biology of head and neck cancer,” Nature Reviews Cancer, vol. 11, no. 1, pp. 9–22, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. W. J. Blot, J. K. McLaughlin, D. M. Winn et al., “Smoking and drinking in relation to oral and pharyngeal cancer,” Cancer Research, vol. 48, no. 11, pp. 3282–3287, 1988. View at Google Scholar · View at Scopus
  5. A. J. Tuyns, J. Esteve, L. Raymond et al., “Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France),” International Journal of Cancer, vol. 41, no. 4, pp. 483–491, 1988. View at Google Scholar · View at Scopus
  6. M. P. Curado and M. Hashibe, “Recent changes in the epidemiology of head and neck cancer,” Current Opinion in Oncology, vol. 21, no. 3, pp. 194–200, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. G. D'Souza, A. R. Kreimer, R. Viscidi et al., “Case-control study of human papillomavirus and oropharyngeal cancer,” New England Journal of Medicine, vol. 356, no. 19, pp. 1944–1956, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Goldenberg, J. Lee, W. M. Koch et al., “Habitual risk factors for head and neck cancer,” Otolaryngology-Head and Neck Surgery, vol. 131, no. 6, pp. 986–993, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Díez-Pérez, J. Campo-Trapero, J. Cano-Sánchez et al., “Methylation in oral cancer and pre-cancerous lesions (review),” Oncology Reports, vol. 25, no. 5, pp. 1203–1209, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. P. A. Jones and S. B. Baylin, “The fundamental role of epigenetic events in cancer,” Nature Reviews Genetics, vol. 3, no. 6, pp. 415–428, 2002. View at Google Scholar · View at Scopus
  11. J. G. Herman and S. B. Baylin, “Gene silencing in cancer in association with promoter hypermethylation,” New England Journal of Medicine, vol. 349, no. 21, pp. 2042–2054, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. S. B. Baylin and P. A. Jones, “A decade of exploring the cancer epigenome-biological and translational implications,” Nature Reviews Cancer, vol. 11, no. 10, pp. 726–734, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Stebbing, M. Bower, N. Syed, P. Smith, V. Yu, and T. Crook, “Epigenetics: an emerging technology in the diagnosis and treatment of cancer,” Pharmacogenomics, vol. 7, no. 5, pp. 747–757, 2006. View at Publisher · View at Google Scholar · View at Scopus
  14. R. L. Momparler, “Cancer epigenetics,” Oncogene, vol. 22, no. 43, pp. 6479–6483, 2003. View at Google Scholar · View at Scopus
  15. R. Sankaranarayanan, E. Masuyer, R. Swaminathan, J. Ferlay, and S. Whelan, “Head and neck cancer: a global perspective on epidemiology and prognosis,” Anticancer Research B, vol. 18, no. 6, pp. 4779–4786, 1998. View at Google Scholar · View at Scopus
  16. P. W. Laird, “The power and the promise of DNA methylation markers,” Nature Reviews Cancer, vol. 3, no. 4, pp. 253–266, 2003. View at Google Scholar · View at Scopus
  17. A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu, and M. J. Thun, “Cancer statistics, 2007,” Ca-A Cancer Journal for Clinicians, vol. 57, no. 1, pp. 43–66, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Antequera and A. Bird, “Number of CpG islands and genes in human and mouse,” Proceedings of the National Academy of Sciences of the United States of America, vol. 90, no. 24, pp. 11995–11999, 1993. View at Publisher · View at Google Scholar · View at Scopus
  19. M. L. Veigl, L. Kasturi, J. Olechnowicz et al., “Biallelic inactivation of hMLH1 by epigenetic gene silencing, a novel mechanism causing human MSI cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 95, no. 15, pp. 8698–8702, 1998. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Esteller, “Cancer epigenetics: DNA methylation and chromatin alterations in human cancer,” Advances in Experimental Medicine and Biology, vol. 532, pp. 39–49, 2003. View at Google Scholar · View at Scopus
  21. J. F. Costello, M. C. Frühwald, D. J. Smiraglia et al., “Aberrant CpG-island methylation has non-random and tumour-type-specific patterns,” Nature Genetics, vol. 24, no. 2, pp. 132–138, 2000. View at Publisher · View at Google Scholar · View at Scopus
  22. C. B. Yoo and P. A. Jones, “Epigenetic therapy of cancer: past, present and future,” Nature Reviews Drug Discovery, vol. 5, no. 1, pp. 37–50, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Pérez-Sayáns, J. M. Suárez-Peñaranda, P. Gayoso-Diz, F. Barros-Angueira, J. M. Gándara-Rey, and A. García-García, “p16INK4A/CDKN2 expression and its relationship with oral squamous cell carcinoma is our current knowledge enough?” Cancer Letters, vol. 306, no. 2, pp. 134–141, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. V. Papadimitrakopoulou, J. Izzo, S. M. Lippman et al., “Frequent inactivation of p16(INK4α) in oral premalignant lesions,” Oncogene, vol. 14, no. 15, pp. 1799–1803, 1997. View at Google Scholar · View at Scopus
  25. V. A. Papadimitrakopoulou, J. Izzo, L. Mao et al., “Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development,” Clinical Cancer Research, vol. 7, no. 10, pp. 3127–3134, 2001. View at Google Scholar · View at Scopus
  26. L. A. Kresty, S. R. Mallery, T. J. Knobloch et al., “Alterations of p16INK4A and p14ARF in patients with severe oral epithelial dysplasia,” Cancer Research, vol. 62, no. 18, pp. 5295–5300, 2002. View at Google Scholar · View at Scopus
  27. G. L. Hall, R. J. Shaw, E. A. Field et al., “p16 promoter methylation is a potential predictor of malignant transformation in oral epithelial dysplasia,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 8, pp. 2174–2179, 2008. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Cao, J. Zhou, Y. Gao et al., “Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study,” Clinical Cancer Research, vol. 15, no. 16, pp. 5178–5183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Kato, A. Hara, T. Kuno et al., “Aberrant promoter hypermethylation of p16 and MGMT genes in oral squamous cell carcinomas and the surrounding normal mucosa,” Journal of Cancer Research and Clinical Oncology, vol. 132, no. 11, pp. 735–743, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Kaur, S. Demokan, S. C. Tripathi et al., “Promoter hypermethylation in Indian primary oral squamous cell carcinoma,” International Journal of Cancer, vol. 127, no. 10, pp. 2367–2373, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. P. Sinha, S. Bahadur, A. Thakar et al., “Significance of promoter hypermethylation of p16 gene for margin assessment in carcinoma tongue,” Head and Neck, vol. 31, no. 11, pp. 1423–1430, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. S. Ohta, H. Uemura, Y. Matsui et al., “Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 107, no. 1, pp. 81–91, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. C. L. Wu, L. Roz, S. McKown et al., “DNA studies underestimate the major role of CDKN2A inactivation in oral and oropharyngeal squamous cell carcinomas,” Genes Chromosomes and Cancer, vol. 25, no. 1, pp. 16–25, 1999. View at Google Scholar · View at Scopus
  34. M. de Freitas Cordeiro-Silva, E. Stur, L. P. Agostini et al., “Promoter hypermethylation in primary squamous cell carcinoma of the oral cavity and oropharynx: a study of a Brazilian cohort,” Molecular Biology Reports, vol. 39, no. 12, pp. 10111–10119, 2012. View at Publisher · View at Google Scholar
  35. M. Viswanathan, N. Tsuchida, and G. Shanmugam, “Promoter hypermethylation profile of tumor-associated genes p16, p15, hMLH1, MGMT and E-cadherin in oral squamous cell carcinoma,” International Journal of Cancer, vol. 105, no. 1, pp. 41–46, 2003. View at Publisher · View at Google Scholar · View at Scopus
  36. D. Goldenberg, S. Harden, B. G. Masayesva et al., “Intraoperative molecular margin analysis in head and neck cancer,” Archives of Otolaryngology-Head and Neck Surgery, vol. 130, no. 1, pp. 39–44, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. R. J. Shaw, T. Liloglou, S. N. Rogers et al., “Promoter methylation of P16, RARβ, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing,” British Journal of Cancer, vol. 94, no. 4, pp. 561–568, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. G. Supic, R. Kozomara, N. Jovic, K. Zeljic, and Z. Magic, “Prognostic significance of tumor-related genes hypermethylation detected in cancer-free surgical margins of oral squamous cell carcinomas,” Oral Oncology, vol. 47, no. 8, pp. 702–708, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. D. P. Slaughter, H. W. Southwick, and W. Smejkal, “Field cancerization in oral stratified squamous epithelium; clinical,” Cancer, vol. 6, no. 5, pp. 963–968, 1953. View at Google Scholar · View at Scopus
  40. R. Sailasree, A. Abhilash, K. M. Sathyan, K. R. Nalinakumari, S. Thomas, and S. Kannan, “Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 2, pp. 414–420, 2008. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Ogi, M. Toyota, M. Ohe-Toyota et al., “Aberrant methylation of multiple genes and clinicopathological features in oral squamous cell carcinoma,” Clinical Cancer Research, vol. 8, no. 10, pp. 3164–3171, 2002. View at Google Scholar · View at Scopus
  42. E. Ishida, M. Nakamura, M. Ikuta et al., “Promotor hypermethylation of p14ARF is a key alteration for progression of oral squamous cell carcinoma,” Oral Oncology, vol. 41, no. 6, pp. 614–622, 2005. View at Publisher · View at Google Scholar · View at Scopus
  43. Y. Dong, J. Wang, F. Dong, X. Wang, and Y. Zhang, “The correlations between alteration of p16 gene and clinicopathological factors and prognosis in squamous cell carcinomas of the buccal mucosa,” Journal of Oral Pathology and Medicine, vol. 41, no. 6, pp. 463–469, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. E. M. O'Regan, M. E. Toner, S. P. Finn et al., “p16INK4A genetic and epigenetic profiles differ in relation to age and site in head and neck squamous cell carcinomas,” Human Pathology, vol. 39, no. 3, pp. 452–458, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. T. Fonseca-Silva, L. C. Farias, C. M. Cardoso et al., “Analysis of p16CDKN2A methylation and HPV-16 infection in oral mucosal dysplasia,” Pathobiology, vol. 79, no. 2, pp. 94–100, 2012. View at Publisher · View at Google Scholar · View at Scopus
  46. P. M. Weinberger, Z. Yu, B. G. Haffty et al., “Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer,” Clinical Cancer Research, vol. 10, no. 17, pp. 5684–5691, 2004. View at Publisher · View at Google Scholar · View at Scopus
  47. R. J. Shaw, G. L. Hall, D. Lowe et al., “CpG island methylation phenotype (CIMP) in oral cancer: associated with a marked inflammatory response and less aggressive tumour biology,” Oral Oncology, vol. 43, no. 9, pp. 878–886, 2007. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Baba, A. Hara, K. Kato et al., “Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas,” Oncology Reports, vol. 22, no. 5, pp. 1173–1179, 2009. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Toyota, Y. Sasaki, A. Satoh et al., “Epigenetic inactivation of CHFR in human tumors,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 13, pp. 7818–7823, 2003. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Shintani, Y. Nakahara, M. Mihara, Y. Ueyama, and T. Matsumura, “Inactivation of the p14ARF, p15INK4B and p16INK4A genes is a frequent event in human oral squamous cell carcinomas,” Oral Oncology, vol. 37, no. 6, pp. 498–504, 2001. View at Publisher · View at Google Scholar · View at Scopus
  51. D. M. Kordi-Tamandani, A. Moazeni-Roodi, M. A. R. Ladez, M. Hashemi, E. Birjandian, and A. Torkamanzehi, “Analysis of methylation patterns and expression profiles of p14ARF gene in patients with oral squamous cell carcinoma,” International Journal of Biological Markers, vol. 25, no. 2, pp. 99–103, 2010. View at Google Scholar · View at Scopus
  52. Y. Nakahara, S. Shintani, M. Mihara, Y. Ueyama, and T. Matsumura, “High frequency of homozygous deletion and methylation of p16INK4A gene in oral squamous cell carcinomas,” Cancer Letters, vol. 163, no. 2, pp. 221–228, 2001. View at Publisher · View at Google Scholar · View at Scopus
  53. M. J. Huang, K. T. Yeh, H. C. Shih et al., “The correlation between CpG methylation and protein expression of P16 in oral squamous cell carcinomas,” International Journal of Molecular Medicine, vol. 10, no. 5, pp. 551–554, 2002. View at Google Scholar · View at Scopus
  54. K. T. Yeh, J. G. Chang, T. H. Lin et al., “Epigenetic changes of tumor suppressor genes, P15, P16, VHL and P53 in oral cancer,” Oncology Reports, vol. 10, no. 3, pp. 659–663, 2003. View at Google Scholar · View at Scopus
  55. R. Czerninski, S. Krichevsky, Y. Ashhab, D. Gazit, V. Patel, and D. Ben-Yehuda, “Promoter hypermethylation of mismatch repair genes, hMLH1 and hMSH2 in oral squamous cell carcinoma,” Oral Diseases, vol. 15, no. 3, pp. 206–213, 2009. View at Publisher · View at Google Scholar · View at Scopus
  56. S. H. Huang, H. S. Lee, K. Mar, D. Ji, M. Huang, and K. Hsia, “Loss expression of O6-methylguanine DNA methyltransferase by promoter hypermethylation and its relationship to betel quid chewing in oral squamous cell carcinoma,” Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontology, vol. 109, no. 6, pp. 883–889, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. G. Supic, R. Kozomara, N. Jovic, K. Zeljic, and Z. Magic, “Hypermethylation of RUNX3 but not WIF1 gene and its association with stage and nodal status of tongue cancers,” Oral Diseases, vol. 17, no. 8, pp. 794–800, 2011. View at Publisher · View at Google Scholar · View at Scopus
  58. F. Gao, C. Huang, M. Lin et al., “Frequent inactivation of RUNX3 by promoter hypermethylation and protein mislocalization in oral squamous cell carcinomas,” Journal of Cancer Research and Clinical Oncology, vol. 135, no. 5, pp. 739–747, 2009. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Sogabe, H. Suzuki, M. Toyota et al., “Epigenetic inactivation of SFRP genes in oral squamous cell carcinoma,” International Journal of Oncology, vol. 32, no. 6, pp. 1253–1261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. H. W. Chang, V. Chow, K. Y. Lam, W. I. Wei, and A. P. WingYuen, “Loss of E-cadherin expression resulting from promoter hypermethylation in oral tongue carcinoma and its prognostic significance,” Cancer, vol. 94, no. 2, pp. 386–392, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. R. V. de Moraes, D. T. Oliveira, G. Landman et al., “E-cadherin abnormalities resulting from CPG methylation promoter in metastatic and nonmetastatic oral cancer,” Head and Neck, vol. 30, no. 1, pp. 85–92, 2008. View at Publisher · View at Google Scholar · View at Scopus
  62. K. T. Yeh, M. C. Shih, T. H. Lin et al., “The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma,” Anticancer Research C, vol. 22, no. 6, pp. 3971–3975, 2002. View at Google Scholar · View at Scopus
  63. K. H. Huang, S. F. Huang, I.-H. Chen, C. Liao, H. Wang, and L. Hsieh, “Methylation of RASSF1A, RASSF2A, and HIN-1 is associated with poor outcome after radiotherapy, but not surgery, in oral squamous cell carcinoma,” Clinical Cancer Research, vol. 15, no. 12, pp. 4174–4180, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. K. M. Pattani, Z. Zhang, S. Demokan et al., “Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy,” Cancer Prevention Research, vol. 3, no. 9, pp. 1093–1103, 2010. View at Publisher · View at Google Scholar · View at Scopus